Delivery Order HHSN271201100004I-HHSN27100004

Award Date 9/11/12
Potential Completion Date 9/12/16
Potential Value $441K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a task order award under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract with the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,909,141.00 task order is for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" and has a completion date of May 19, 2022. The prime contractor is Sri International, a non-profit research institute that provides a...
This task order was awarded by the National Institutes of Health (NIH), a component of the Department of Health and Human Services (HHS), to the non-profit research institute SRI International. The $531,805.00 task order is for interaction safety studies in rats using whole body plethysmography, supporting the NIH's National Institute on Drug Abuse's toxicological evaluations of potential medications program. The period of performance is from August 1, 2019 to July 31, 2020, with a current...
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the non-profit research institute SRI International. The $3,919,858.62 task order is for a 39-week oral toxicology and toxicokinetic study in mature cynomolgus monkeys with the drug candidate PA-824, with a 12-week recovery period. This work falls under NIAID's broader "Preclinical Services for the Development...
This is a $7,323,160.93 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS). The contract is for continuous rodent and non-rodent pharmacokinetic assessments under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ contract. The prime contractor is SRI International, a large non-profit research and development institute that frequently partners...
This federal contract award to SRI International, a non-profit research and development institute, is for $1,469,307.00 to conduct rodent and non-rodent pharmacokinetic studies. The contract is a delivery order issued under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master IDIQ contract with the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health within the Department of Health and Human Services, to Pharmaron, Inc. for $64,090. The contract is for Pharmaron to conduct a 14-day dose range-finding toxicity study in male and female rats to determine the maximally tolerated dose of an investigational molecule under development by NCATS. Specifically, Pharmaron will test the...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...
This is a Cost Plus Fixed Fee delivery order awarded to SRI International, a non-profit research and development institute, by the National Institute on Drug Abuse (NIDA) under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $2,343,369.90 and a period of performance ending on March 31, 2022. SRI International will provide pharmacology and toxicology services for the PTTP. The contract...
This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The contract is valued at $24,320.00 and does not have a set-aside designation. The contract is for pharmacokinetic studies of two compounds in non-naive cynomolgus monkeys, using both oral and intravenous routes of administration, with bioanalyses in plasma conducted in triplicate. This...
This is a task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to SRI International, a non-profit research and development institute. The $1,310,031.26 cost-plus-fixed-fee task order is to conduct the following work: (1) toxicology studies of a tenofovir nanoformulation with pharmacokinetics in mice, (2) inhalation toxicity studies of clofazimine in rats, and (3) support the development of mitochondrial toxicity assays. This task...

"OTHER FUNCTIONS" SRI (TASK ORDER 4) ENTITLED, "RODENT PHARMACOKINETIC AND BRAIN LEVEL DETERMINATION".

Posted 9/11/12